Back
HFA Premium Access

First in Human Experience with Alfapump DSR System in Diuretic Resistant Chronic Heart Failure

Session: Clinical Trial Updates
Topic: Treatment
Speaker: Associate Professor J. Testani (New Haven, US)
Event: Heart Failure 2021

Congress Presentation

About the speaker

Associate Professor Jeffrey Testani

Yale School of Medicine, New Haven (United States of America)
6 presentations
0 follower

13 more presentations in this session

Omecamtiv Mecarbil in Patients with Severe Heart Failure: An Analysis from Global Approach to Lowering Adverse Cardiac Outcomes through Improving Contractility in Heart Failure (GALACTIC-HF)

Speaker: Professor G. Felker (Durham, US)

Access
Slides
Video
Thumbnail

Association of Baseline Cardiac Biomarkers on Clinical Outcomes and Vericiguat Treatment Effect in Heart Failure with Reduced Ejection Fraction: Insights from the VICTORIA Trial

Speaker: Associate Professor C. DeFilippi (Baltimore, US)

Access
Slides
Video
Thumbnail

Efficacy and Safety of Antithrombotic Strategies in Patients With Atrial Fibrillation and Recent ACS or PCI With and Without A History of Heart Failure: Insights From the AUGUSTUS Trial

Speaker: Doctor M. Fudim (Durham, US)

Access
Slides
Video
Thumbnail

Nurse Intervention for Less Chronic Heart Failure Study

Speaker: Professor S. Stewart (Adelaide, AU)

Access
Slides
Video
Thumbnail

Efficacy of omecamtiv mecarbil in heart failure with reduced ejection fraction according to N-terminal pro-B-type natriuretic peptide level: Insights from the GALACTIC-HF trial.

Speaker: Professor J. McMurray (Glasgow, GB)

Access
Slides
Video
Thumbnail

Access the full session

Clinical Trial Updates

Speakers: Associate Professor J. Testani, Professor G. Felker, Associate Professor C. DeFilippi, Doctor M. Fudim, Professor S. Stewart...
Access
Thumbnail

About the event

Image

Heart Failure 2021

29 June - 1 July 2021

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb